Page last updated: 2024-08-26

methoxyfenozide and Peripheral Arterial Diseases

methoxyfenozide has been researched along with Peripheral Arterial Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ariotti, S; Baldo, A; Franzone, A; Gargiulo, G; Magnani, G; Marino, M; Moschovitis, A; Piccolo, R; Santucci, A; Valgimigli, M; Windecker, S	1

Trials

1 trial(s) available for methoxyfenozide and Peripheral Arterial Diseases

Article	Year
Prolonged vs Short Duration of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With or Without Peripheral Arterial Disease: A Subgroup Analysis of the PRODIGY Randomized Clinical Trial. JAMA cardiology, 2016, 10-01, Volume: 1, Issue:7 Topics: Aged; Aspirin; Composite Resins; Coronary Artery Disease; Drug Therapy, Combination; Female; Humans; Hyperplasia; Male; Middle Aged; Percutaneous Coronary Intervention; Peripheral Arterial Disease; Platelet Aggregation Inhibitors; Stents; Tunica Intima	2016

Article

Year

Prolonged vs Short Duration of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With or Without Peripheral Arterial Disease: A Subgroup Analysis of the PRODIGY Randomized Clinical Trial.

JAMA cardiology, 2016, 10-01, Volume: 1, Issue:7

Topics: Aged; Aspirin; Composite Resins; Coronary Artery Disease; Drug Therapy, Combination; Female; Humans; Hyperplasia; Male; Middle Aged; Percutaneous Coronary Intervention; Peripheral Arterial Disease; Platelet Aggregation Inhibitors; Stents; Tunica Intima

2016